Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02771977 · ClinicalTrials.gov registry record · NA
Drug-Targeted Alerts for Acute Kidney Injury
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 5,060
- Enrollment target
NCT02771977 is a NA study that has completed, run by Yale University. The registered enrollment target is 5,060 participants.
The verdict
NCT02771977, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,060 participants
- Enrollment target
Study Summary
In this trial, patients with acute kidney injury who have recently received a drug that may affect kidney function will be randomized to having an alert placed in the electronic health record or usual care.
Interventions
- OTHER Drug-specific alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,060 participants |
| Start Date | 2020-08-24 |
| Est. Completion | 2022-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02771977
The ClinicalTrials.gov registry entry for NCT02771977 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,060 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Drug-specific alert is the first listed.
NCT02771977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02771977 about?
NCT02771977 is a clinical study titled "Drug-Targeted Alerts for Acute Kidney Injury". In this trial, patients with acute kidney injury who have recently received a drug that may affect kidney function will be randomized to having an alert placed in the electronic health record or usual care.
What is the current status of trial NCT02771977?
This trial is currently completed. It is a NA study. The enrollment target is 5,060 participants. The study started on 2020-08-24. Estimated completion is 2022-01-04.
What interventions are being tested in trial NCT02771977?
The interventions under investigation include: Drug-specific alert (OTHER).
Who is sponsoring clinical trial NCT02771977?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.